2,4-diaminobutyric acid has been researched along with B16 Melanoma in 1 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwashita, Y | 1 |
| Ogawa, T | 1 |
| Goto, S | 1 |
| Nakanishi, M | 1 |
| Goto, T | 1 |
| Kitano, S | 1 |
1 other study available for 2,4-diaminobutyric acid and B16 Melanoma
| Article | Year |
|---|---|
Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
Topics: Aminobutyrates; Animals; Cell Line, Tumor; Genetic Therapy; Genetic Vectors; Interferon-gamma; Inter | 2004 |